C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/85 (2006.01) A01K 67/027 (2006.01) A61K 35/12 (2006.01) A61K 35/28 (2006.01) A61K 39/00 (2006.01) A61K 39/108 (2006.01) A61K 48/00 (2006.01) A61P 31/04 (2006.01) A61P 35/00 (2006.01) C12N 5/10 (2006.01) C12N 9/78 (2006.01) C12N 15/55 (2006.01) C12N 15/867 (2006.01) C12Q 1/02 (2006.01)
Patent
CA 2112395
The present invention relates to a system comprising a modified bacterial gene for cytosine deaminase that has been engineered into a eukaryotic expression vector and the expression of the gene by murine fibroblasts. The present invention further relates to methods, gene therapies and vaccines that employ the negative selectable marker, cytosine deaminase, which has the ability to produce a toxic antimetabolite 5-fluorouracil from 5- fluorocytosine.
Blaese R. Michael
Mullen Craig A.
Department O. F. Health And Human Services The United States Of America Represented By The Secretary
Fetherstonhaugh & Co.
LandOfFree
Cytosine deaminase negative selection system for gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytosine deaminase negative selection system for gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytosine deaminase negative selection system for gene... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2014021